Treatment

Response to ’Response to viewpoint ’Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs et al
Maya H Buch

Annals of the Rheumatic Diseases Aug 2018, annrheumdis-2018-214153; DOI: 10.1136/annrheumdis-2018-214153
Digital health in rheumatology
Vinod Ravindran, Suchitra Kataria

Annals of the Rheumatic Diseases Aug 2018, annrheumdis-2018-214146; DOI: 10.1136/annrheumdis-2018-214146
Response to: ’Early identification of rheumatoid arthritis; the risk of overtreatment in perspective' by Landewé
Robert B M Landewé

Annals of the Rheumatic Diseases Aug 2018, annrheumdis-2018-214172; DOI: 10.1136/annrheumdis-2018-214172
Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis
Gabriella Moroni, Paolo Gilles Vercelloni, Silvana Quaglini, Mariele Gatto, Davide Gianfreda, Lucia Sacchi, Francesca Raffiotta, Margherita Zen, Gloria Costantini, Maria Letizia Urban, Federico Pieruzzi, Piergiorgio Messa, Augusto Vaglio, Renato Alberto Sinico, Andrea Doria

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1318-1325; DOI: 10.1136/annrheumdis-2017-212732
Bisphosphonates: a therapeutic option for knee osteoarthritis?
Willem F Lems

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1247-1248; DOI: 10.1136/annrheumdis-2017-212364
Uric acid and incident dementia: a population-based cohort study
Young Ho Lee, Gwan Gyu Song

Annals of the Rheumatic Diseases Sep 2018, 77 (9) e62; DOI: 10.1136/annrheumdis-2017-212570
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, Joachim Sieper, Pentti Järvinen, Lai-Shan Tam, Carlo Salvarani, Tae-Hwan Kim, Alan Solinger, Yakov Datsenko, Chandrasena Pamulapati, Sudha Visvanathan, David B Hall, Stella Aslanyan, Paul Scholl, Steven J Padula

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1295-1302; DOI: 10.1136/annrheumdis-2018-213328
How useful is PET/CT in the evaluation of fever/inflammation of unknown origin? Comment on the article by Schönau et al
Markus Bredemeier

Annals of the Rheumatic Diseases Sep 2018, 77 (9) e61; DOI: 10.1136/annrheumdis-2017-212483
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the STARTER study
Georgios Filippou, Garifallia Sakellariou, Carlo Alberto Scirè, Greta Carrara, Federica Rumi, Emanuela Bellis, Antonella Adinolfi, Alberto Batticciotto, Alessandra Bortoluzzi, Giovanni Cagnotto, Marta Caprioli, Marco Canzoni, Francesco Paolo Cavatorta, Orazio De Lucia, Valentina Di Sabatino, Antonella Draghessi, Ilaria Farina, Maria Cristina Focherini, Alessandra Gabba, Marwin Gutierrez, Luca Idolazzi, Filippo Luccioli, Pierluigi Macchioni, Marco Sergio Massarotti, Claudio Mastaglio, Luana Menza, Maurizio Muratore, Simone Parisi, Valentina Picerno, Matteo Piga, Roberta Ramonda, Bernd Raffeiner, Daniela Rossi, Silvia Rossi, Paola Rossini, Crescenzio Scioscia, Carlo Venditti, Alessandro Volpe, Annamaria Iagnocco

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1283-1289; DOI: 10.1136/annrheumdis-2018-213217
Response to: ‘Digital health: a new dimension in rheumatology patient care’ by Kataria and Ravindran
Gerd R Burmester

Annals of the Rheumatic Diseases Aug 2018, annrheumdis-2018-214154; DOI: 10.1136/annrheumdis-2018-214154

Main menu

Treatment

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Treatment

Pages